Mobile

Multicenter, randomized, open-label trial to evaluate the safety, tolerability and efficacy of two regimens of Everolimus plus Neoral, given according different blood target levels, in de novo renal t...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-000864-16

Multicenter, randomized, open-label trial to evaluate the safety, tolerability and efficacy of two regimens of Everolimus plus Neoral, given according different blood target levels, in de novo renal transplant recipients Everest the upper target EVErolimus RandomizEd STudy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Critère d'inclusion

  • Prevention of rejection in adult renal transplant patients in combination with Neoral and corticosteroids

Liens